PATENT CLAIM ANALYSIS

Application Number: 16182720
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-03
Patent Classification: ["514", "411000"]

Abstract:
Small molecule carbazole compounds for use as androgen receptor inhibitors are provided herein. Also provided herein are methods for using the carbazole compounds in treating prostate cancer, including castration-resistant prostate cancer and enzalutamide-resistant prostate cancer. The methods include administering to a subject an effective amount of a compound or composition as described herein.

Claim (Index 17):
The method of  claim 9 , further comprising administering a second therapeutic agent to the subject, wherein the second therapeutic agent is a chemotherapeutic agent.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 98.0
- Lexical Diversity: 1.39024
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15749383', '15346743', '15222734', '15331777', '15135334']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.759290294905151
- 35 USC 102 Novelty (BERT): 0.6798738075598315
- Combined Prediction Score: 0.7513486461706191
- Mean Citation Score: 459.834436
- Max Citation Score: 712.17395
- Similarity Product: 649.8431251684367

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test